Dr. D. Martin Alexander Gershon, MD, JD, Mph
About Dr. D. Martin Alexander Gershon, MD, JD, Mph
Dr Gershon is the Managing Partner & CIO of Endeavor Life Sciences Venture Funds & Venture Studio, Senior Executive Investor in Residence of Techstars, and Advisor to the White House Moonshot CancerX Accelerator He has been featured on CNBC & in numerous conferences & publications as a leading healthcare investor, strategist, futurist & entrepreneur. He has been honored by Standard and Poor’s as a designated Top 100 “Healthcare Industry Leader”, recognized by Linkedin as a “Top Voice in Venture Capital and Entrepreneurship”, and is a contributing author of healthcare entrepreneurship and venture capital at Fast Company He has personally founded 6 startups & led Endeavor to 100 investments (https://pitchbook.com/profiles/investor/502794-10#overview). He served as Senior Advisor to Fortune 500 companies including McKinsey, Goldman Sachs, Bain, Fidelity, TPG, BlackRock, Tiger Global, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Novartis Over the past 23 years Dr Gershon has developed an ecosystem of partnerships with Big Tech, Digital Health, BioPharma, Medtech, world class entrepreneurs & accelerators & prominent Ivy League universities & business schools like Harvard, Columbia, NYU, & Johns Hopkins In 2009 Dr Gershon founded Endeavor Life Science Venture Fund, a Series B Fund, investing in groundbreaking biotech life science companies like Moderna. Endeavor’s portfolio companies possess disruptive technologies, strong scalable commercial potential, driven by great entrepreneurs who look for partnerships in the Endeavor ecosystem to help them build their companies into unicorns. Endeavor II was formed in 2022 primarily investing in emerging digital healthtech companies Endeavor Venture Studio-designed as a bridge from accelerators to commercialization-was also established in 2022 investing in pre-seed to Series A. The Studio provides sustained financial support ($100-500k checks up to $5M) over 4 years as well as operational & strategic support in an ecosystem of seasoned entrepreneurs, subject matter experts & business leaders dedicated to help CEOs with deal making, partnering, negotiating and bespoke revenue generating Go-to-Market strategies to drive new collaborations, use cases and revenue streams with our partners. Dr Gershon is a Harvard, Columbia Presbyterian & Sloan-Kettering trained Mayday Fellow, neuroscientist, oncologist, immunologist, FDA attorney, & Lecturer/Professor at Harvard, MIT, McGill, Johns Hopkins, Oxford, NYU & Columbia Universities